Lupin unveils Rymti biosimilar Etanercept in Canada
Mumbai: Global pharma major Lupin Limited has announced the launch of Rymti, Lupin's first biosimilar in Canada, through its partner Sandoz Canada. Rymti is indicated for the treatment of moderate to severe active rheumatoid arthritis, juvenile …